IPA logo

ImmunoPrecise Antibodies (IPA)

Profile

Full Name

ImmunoPrecise Antibodies Ltd.

Ticker Symbol

IPA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 7, 2002

Indexes

Not included

Website

http://www.ipatherapeutics.com

Employees

72

Key Details

Price

$0.46(+6.03%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$18.16M(+16.83% YoY)

Annual EPS

-$0.78(+2.45% YoY)

PE ratio

-

Next earnings date

Jul 29, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.46
IPA price is $0.46

30-Day Relative Volume

0.36
IPA 30-day relative volume is 0.36

Price Performance

Price Most recent change

+6.03%
IPA price was up +6.03% on Apr 14, 2025

Price YTD change

+10.92%
IPA price is up +10.92% since January 1st

Price 1-year change

-63.15%
IPA price is down -63.15% year-on-year

Price 3-year change

-92.01%
IPA price is down -92.01% over the past 3 years

Price Range

Price All-time high

$42.75
IPA price is currently -98.93% below its historical high of $42.75

Price 3-year low

$0.27
IPA price is currently +69.26% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$20.91M
IPA market capitalization is $20.91 million

Market cap 3-year change

-84.47%
IPA market capitalization is down -84.47% over the past 3 years

Market cap All-time high

$314.32M
IPA market capitalization is currently -93.35% below its historical high of $314.32 million

Market cap sector rank

27.88%
IPA market capitalization is higher than 27.88% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+73.91%
IPA shares outstanding is up +73.91% year-on-year

Shares Outstanding 3-Year Change

+94.42%
IPA shares outstanding is up +94.42% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.72
IPA beta is 0.72

200-day SMA

$0.57
IPA price is currently -19.54% below its 200-day simple moving average

50-day SMA

$0.41
IPA price is currently +11.68% above its 50-day simple moving average

RSI

59.01
IPA 14-day relative strength index is 59.01

Volume

0.36
IPA 30-day relative volume is 0.36

ATR

$0.05
IPA average true range is $0.05

10-day Historical Volatility

107.08%
IPA 10-day historical volatility is 107.08%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$18.16M
IPA annual revenue is $18.16 million

Revenue Analysts estimate

$25.43M
IPA annual revenue is currently -28.60% lower than the consensus analysts' forecast

Revenue 1-year change

+16.83%
IPA annual revenue is up +16.83% year-on-year

Revenue Sector rank

33.15%
IPA annual revenue is higher than 33.15% of companies in Healthcare sector

EPS

EPS

-$0.78
IPA annual earnings per share is -$0.78

EPS Analysts estimate

-
IPA annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+2.45%
IPA annual earnings per share is up +2.45% year-on-year

EPS Sector rank

61.21%
IPA annual earnings per share is higher than 61.21% of companies in Healthcare sector

Profit

Gross profit

$8.93M
IPA annual gross profit is $8.93 million

Gross margin

49.16%
IPA annual gross profit margin is 49.16%

Operating profit

-$10.19M
IPA annual operating income is -$10.19 million

Operating margin

-56.13%
IPA annual operating profit margin is -56.13%

Net income

-$20.12M
IPA annual net profit is -$20.12 million

Net margin

-110.85%
IPA annual net profit margin is -110.85%

Expenses

Total expenses

$28.35M
IPA annual total expenses is $28.35 million

Operating expenses

$19.12M
IPA annual total operating expenses is $19.12 million

Cost of goods sold

$9.23M
IPA annual cost of goods sold is $9.23 million

Selling, general & administrative expenses

$14.17M
IPA annual SGA is $14.17 million

Depreciation and amortization

$4.25M
IPA annual depreciation & amortization is $4.25 million

Interest expense

$14.10K
IPA annual interest expense is $14.10 thousand

Income tax

-$1.13M
IPA annual income tax is -$1.13 million

EBIT & EBITDA

EBIT

-$21.24M
IPA annual earnings before interest & taxes is -$21.24 million

EBITDA

-$16.99M
IPA annual EBITDA is -$16.99 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$43.89M
IPA annual total assets is $43.89 million

Non current assets

$35.49M
IPA annual long term assets is $35.49 million

Current assets

$8.40M
IPA annual total current assets is $8.40 million

Cash and cash equivalents

$2.53M
IPA annual cash & cash equivalents is $2.53 million

Accounts receivable

$2.77M
IPA annual accounts receivable is $2.77 million

Inventory

$1.56M
IPA annual inventory is $1.56 million

Liabilities

Total liabilities

$19.07M
IPA annual total liabilities is $19.07 million

Long term liabilities

$13.13M
IPA annual total long term liabilities is $13.13 million

Current liabilities

$5.94M
IPA annual total current liabilities is $5.94 million

Accounts payable

$3.20M
IPA annual accounts payable is $3.20 million

Debt

Total debt

$10.01M
IPA annual total debt is $10.01 million

Total debt 1-year change

+88.13%
IPA annual total debt is up +88.13% year-on-year

Long term debt

$8.87M
IPA annual long term debt is $8.87 million

Short term debt

$1.14M
IPA annual short term debt is $1.14 million

Equity & Capital

Shareholders equity

$24.82M
IPA annual stockholders equity is $24.82 million

Book value

$24.82M
IPA annual book value is $24.82 million

Retained earnings

-$73.36M
IPA annual retained earnings is -$73.36 million

Working capital

$2.46M
IPA annual working capital is $2.46 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$3.14M
IPA annual cash flow from operations is -$3.14 million

Cash from operations 1-year change

+78.92%
IPA annual cash flow from operations is up +78.92% year-on-year

Cash from investing

-$1.16M
IPA annual cash flow from investing activities is -$1.16 million

Cash from investing 1-year change

+21.76%
IPA annual cash flow from investing activities is up +21.76% year-on-year

Cash from financing

$756.00K
IPA annual cash flow from financing activities is $756.00 thousand

Cash from financing 1-year change

+261.88%
IPA annual cash flow from financing activities is up +261.88% year-on-year

CAPEX

CAPEX

$1.03M
IPA annual capital expenditures is $1.03 million

CAPEX 1-year change

-7.98%
IPA annual capital expenditures is down -7.98% year-on-year

Free Cash Flow

Free cash flow

-$4.18M
IPA annual free cash flow is -$4.18 million

Free cash flow 1-year change

+73.95%
IPA annual free cash flow is up +73.95% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

49.16%
IPA annual gross profit margin is 49.16%

Operating margin

-56.13%
IPA annual operating profit margin is -56.13%

Net margin

-110.85%
IPA annual net profit margin is -110.85%

ROA & ROE

ROA

-39.90%
IPA annual return on assets is -39.90%

ROE

-59.95%
IPA annual return on equity is -59.95%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
IPA price to earnings ratio value is unknown

PE ratio Sector rank

-
IPA price to earnings ratio is unknown

PB Ratio

PB ratio

1.21
IPA price to book ratio is 1.21

PB ratio Sector rank

48.56%
IPA price to book ratio is higher than 48.56% of companies in Healthcare sector

PS Ratio

PS ratio

1.20
IPA price to sales ratio is 1.20

PS ratio Sector rank

30.64%
IPA price to sales ratio is higher than 30.64% of companies in Healthcare sector

Enterprise value

Enterprise value

$20.92M
IPA enterprise value is $20.92 million

Enterprise value Sector rank

32.81%
IPA enterprise value is higher than 32.81% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.65
IPA EV/EBITDA is -0.65

EV/EBITDA Sector rank

48.7%
IPA EV/EBITDA is higher than 48.7% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.41
IPA annual current ratio is 1.41

Quick ratio

1.15
IPA annual quick ratio is 1.15

Leverage

Debt to equity

0.00
IPA annual debt to equity ratio is 0.00

Interest coverage ratio

-1506.40
IPA annual interest coverage ratio is -1506.40

Risk & Stability

Piotroski F-Score

5
IPA piotroski f-score is 5

Altman Z-Score

-2.80
IPA altman z-score is -2.80

Analyst ratings

Recent major analysts updates

Apr 11, 25 HC Wainwright & Co.
Buy
Apr 1, 25 Benchmark
Speculative Buy
Mar 31, 25 HC Wainwright & Co.
Buy
Mar 14, 25 HC Wainwright & Co.
Buy
Dec 11, 24 HC Wainwright & Co.
Buy
Sep 17, 24 HC Wainwright & Co.
Buy
Aug 14, 24 Benchmark
Speculative Buy
Jul 30, 24 HC Wainwright & Co.
Buy
Mar 15, 24 HC Wainwright & Co.
Buy
Mar 15, 24 Benchmark
Speculative Buy

Institutional Ownership

Similar stocks

ENLV logo
Enlivex Therapeutics (ENLV)
RVP logo
Retractable Technologies (RVP)
CYTH logo
Cyclo Therapeutics (CYTH)
XAIR logo
Beyond Air (XAIR)
NEPH logo
Nephros (NEPH)
OVID logo
Ovid Therapeutics (OVID)
FNCH logo
Finch Therapeutics (FNCH)
CDIO logo
Cardio Diagnostics Holdings (CDIO)
LGVN logo
Longeveron (LGVN)
  • What is the ticker symbol for ImmunoPrecise Antibodies?
  • Does ImmunoPrecise Antibodies pay dividends?
  • What sector is ImmunoPrecise Antibodies in?
  • What industry is ImmunoPrecise Antibodies in?
  • What country is ImmunoPrecise Antibodies based in?
  • When did ImmunoPrecise Antibodies go public?
  • Is ImmunoPrecise Antibodies in the S&P 500?
  • Is ImmunoPrecise Antibodies in the NASDAQ 100?
  • Is ImmunoPrecise Antibodies in the Dow Jones?
  • When was ImmunoPrecise Antibodies's last earnings report?
  • When does ImmunoPrecise Antibodies report earnings?

What is the ticker symbol for ImmunoPrecise Antibodies?

The ticker symbol for ImmunoPrecise Antibodies is NASDAQ:IPA

Does ImmunoPrecise Antibodies pay dividends?

No, ImmunoPrecise Antibodies does not pay dividends

What sector is ImmunoPrecise Antibodies in?

ImmunoPrecise Antibodies is in the Healthcare sector

What industry is ImmunoPrecise Antibodies in?

ImmunoPrecise Antibodies is in the Biotechnology industry

What country is ImmunoPrecise Antibodies based in?

ImmunoPrecise Antibodies is headquartered in United States

When did ImmunoPrecise Antibodies go public?

ImmunoPrecise Antibodies's initial public offering (IPO) was on January 7, 2002

Is ImmunoPrecise Antibodies in the S&P 500?

No, ImmunoPrecise Antibodies is not included in the S&P 500 index

Is ImmunoPrecise Antibodies in the NASDAQ 100?

No, ImmunoPrecise Antibodies is not included in the NASDAQ 100 index

Is ImmunoPrecise Antibodies in the Dow Jones?

No, ImmunoPrecise Antibodies is not included in the Dow Jones index

When was ImmunoPrecise Antibodies's last earnings report?

ImmunoPrecise Antibodies's most recent earnings report was on Mar 28, 2025

When does ImmunoPrecise Antibodies report earnings?

The next expected earnings date for ImmunoPrecise Antibodies is Jul 29, 2025
On this page